Innovation in the biopharmaceutical industry is a closely monitored driver of positive public health and commercial outcomes. Despite high interest in tracking innovation as a measure of success, ther...
Read moreOryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announces today...
Read moreA UB study published in the journal Neurotherapeutics has validated a new pharmacological target for Alzheimer’s disease. The results show the inhibition of the enzyme soluble epoxide hydrolase (...
Read moreThe results from this study, published in Nature Methods, can support the development of new drugs fighting Alzheimer’s disease or cancer.
Read moreResearchers from IRB Barcelona, the University of Barcelona (UB) and the Sant Joan de Déu Research Institute – Hospital Sant Joan de Déu (SJD) have set up Gate2Brain, a company based on a novel te...
Read moreThe oversubscribed round was co-led by Ysios Capital and INKEF Capital; Lundbeckfonden Ventures and LSP joined the syndicate. Founding investor, BioGeneration Ventures (BGV) and the regional economic ...
Read moreDeepUll announced today the closing of a 3.5 million Euro round Series A financing led by Alta Life Sciences and Kurma Partners and with participation from Axis Participaciones Empresariales and Sofim...
Read moreRainer Rothe, Scientific and Regulatory Affairs Officer at Asphalion, attended the online session “Improving Human Health Through Artificial Intelligence” organised by CataloniaBio & HealthTech in...
Read moreYsios Capital, a leading biotechnology venture capital firm in Spain, today announced its third fund, Ysios BioFund III, with a committed amount of € 155M and a final target size of € 200M.
Read moreThe COVID-19 fund of the Carlos III Health Institute (ISCIII) awards a project to the Barcelona Supercomputing Center (BSC), lead by Víctor Guallar, in collaboration of Nostrum Biodiscovery ...
Read moreIBEC researchers develop new multi-responsive molecules able to self-assemble in water forming fiber-like structures. The so-called discotic molecules show responsiveness to temperature, light, pH, an...
Read moreA study by the URV’s Cheminformatics and Nutrition research group has shown that an anti-inflammatory drug for humans and another for animals inhibit a key enzyme in the replication and transcriptio...
Read more